For patients experiencing mild to moderate GI symptoms, initial management should focus on non-pharmacological interventions, including smaller and more frequent meals, avoidance of high-fat or spicy foods, cessation of eating upon early satiety, and adequate hydration and fiber intake
It emphasizes the importance of personalized medicine, where treatment decisions are tailored to the individual's specific health profile and needs.
Consult a Professional If you are pregnant, nursing, or managing a specific health concern, it is always wise to consult with your healthcare provider before starting new supplements
To address this therapeutic gap, we have developed MEDI4166, a novel glucagon-like peptide-1 (GLP-1) receptor agonist peptide fused to a proprotein convertase subtilisin/kexin type 9 (PCSK9) neutralising antibody that allows for glycaemic control and low-density lipoprotein cholesterol (LDL-C) lowering in a single molecule
Tirzepatide in Adults With Type 1 Diabetes: A Phase 2 Randomized Placebo-Controlled Clinical Trial
The results of the adjusted data reflected those following stratification, with only minimal differences